A mutation in myotilin causes spheroid body myopathy

Tatiana Foroud, N. Pankratz, A. P. Batchman, M. W. Pauciulo, Ruben Vidal, L. Miravalle, H. H. Goebel, L. J. Cushman, B. Azzarelli, H. Horak, Martin Farlow, W. C. Nichols

Research output: Contribution to journalArticle

61 Citations (Scopus)

Abstract

BACKGROUND: Spheroid body myopathy (SBM) is a rare, autosomal dominant, neuromuscular disorder, which has only been previously reported in a single large kindred. Identification of the mutated gene in this disorder may provide insight regarding abnormal neuromuscular function. METHODS: The authors completed a detailed clinical evaluation on an extensive kindred diagnosed with SBM. Genome-wide linkage analysis was performed to localize the disease gene to a specific chromosomal region. Further marker genotyping and screening of a positional, functional candidate gene were completed to detect the disease-causing mutation. Pathologic analysis of muscle biopsy was performed on three individuals. Biochemical studies were performed on one muscle biopsy specimen from an affected individual. RESULTS: Linkage to chromosome 5q23-5q31 was detected with a lod score of 2.9. Genotyping of additional markers in a larger sample of family members produced a maximum lod score of 6.1 and narrowed the critical interval to 12.2 cM. Screening of the candidate gene titin immunoglobulin domain protein (TTID, also known as MYOT) detected a cytosine-to-thymine mutation in exon 2 of all clinically affected family members. Similar pathologic changes were present in all muscle biopsy specimens. Immunohistologic and biochemical analysis revealed that the TTID protein, also known as myotilin, is a component of the insoluble protein aggregate. CONCLUSIONS: A novel mutation in the TTID gene results in the clinical and pathologic phenotype termed "spheroid body myopathy." Mutations in this gene also cause limb-girdle muscular dystrophy 1A and are associated with myofibrillar myopathy.

Original languageEnglish
Pages (from-to)1936-1940
Number of pages5
JournalNeurology
Volume65
Issue number12
DOIs
StatePublished - Dec 2005

Fingerprint

Mutation
Genes
Lod Score
Biopsy
Muscles
Connectin
Thymine
Cytosine
Spheroid body myopathy
Exons
Proteins
Chromosomes
Genome
Phenotype

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Foroud, T., Pankratz, N., Batchman, A. P., Pauciulo, M. W., Vidal, R., Miravalle, L., ... Nichols, W. C. (2005). A mutation in myotilin causes spheroid body myopathy. Neurology, 65(12), 1936-1940. https://doi.org/10.1212/01.wnl.0000188872.28149.9a

A mutation in myotilin causes spheroid body myopathy. / Foroud, Tatiana; Pankratz, N.; Batchman, A. P.; Pauciulo, M. W.; Vidal, Ruben; Miravalle, L.; Goebel, H. H.; Cushman, L. J.; Azzarelli, B.; Horak, H.; Farlow, Martin; Nichols, W. C.

In: Neurology, Vol. 65, No. 12, 12.2005, p. 1936-1940.

Research output: Contribution to journalArticle

Foroud, T, Pankratz, N, Batchman, AP, Pauciulo, MW, Vidal, R, Miravalle, L, Goebel, HH, Cushman, LJ, Azzarelli, B, Horak, H, Farlow, M & Nichols, WC 2005, 'A mutation in myotilin causes spheroid body myopathy', Neurology, vol. 65, no. 12, pp. 1936-1940. https://doi.org/10.1212/01.wnl.0000188872.28149.9a
Foroud T, Pankratz N, Batchman AP, Pauciulo MW, Vidal R, Miravalle L et al. A mutation in myotilin causes spheroid body myopathy. Neurology. 2005 Dec;65(12):1936-1940. https://doi.org/10.1212/01.wnl.0000188872.28149.9a
Foroud, Tatiana ; Pankratz, N. ; Batchman, A. P. ; Pauciulo, M. W. ; Vidal, Ruben ; Miravalle, L. ; Goebel, H. H. ; Cushman, L. J. ; Azzarelli, B. ; Horak, H. ; Farlow, Martin ; Nichols, W. C. / A mutation in myotilin causes spheroid body myopathy. In: Neurology. 2005 ; Vol. 65, No. 12. pp. 1936-1940.
@article{fb8df43efc4f4c24ae5863aa7e2b3746,
title = "A mutation in myotilin causes spheroid body myopathy",
abstract = "BACKGROUND: Spheroid body myopathy (SBM) is a rare, autosomal dominant, neuromuscular disorder, which has only been previously reported in a single large kindred. Identification of the mutated gene in this disorder may provide insight regarding abnormal neuromuscular function. METHODS: The authors completed a detailed clinical evaluation on an extensive kindred diagnosed with SBM. Genome-wide linkage analysis was performed to localize the disease gene to a specific chromosomal region. Further marker genotyping and screening of a positional, functional candidate gene were completed to detect the disease-causing mutation. Pathologic analysis of muscle biopsy was performed on three individuals. Biochemical studies were performed on one muscle biopsy specimen from an affected individual. RESULTS: Linkage to chromosome 5q23-5q31 was detected with a lod score of 2.9. Genotyping of additional markers in a larger sample of family members produced a maximum lod score of 6.1 and narrowed the critical interval to 12.2 cM. Screening of the candidate gene titin immunoglobulin domain protein (TTID, also known as MYOT) detected a cytosine-to-thymine mutation in exon 2 of all clinically affected family members. Similar pathologic changes were present in all muscle biopsy specimens. Immunohistologic and biochemical analysis revealed that the TTID protein, also known as myotilin, is a component of the insoluble protein aggregate. CONCLUSIONS: A novel mutation in the TTID gene results in the clinical and pathologic phenotype termed {"}spheroid body myopathy.{"} Mutations in this gene also cause limb-girdle muscular dystrophy 1A and are associated with myofibrillar myopathy.",
author = "Tatiana Foroud and N. Pankratz and Batchman, {A. P.} and Pauciulo, {M. W.} and Ruben Vidal and L. Miravalle and Goebel, {H. H.} and Cushman, {L. J.} and B. Azzarelli and H. Horak and Martin Farlow and Nichols, {W. C.}",
year = "2005",
month = "12",
doi = "10.1212/01.wnl.0000188872.28149.9a",
language = "English",
volume = "65",
pages = "1936--1940",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - A mutation in myotilin causes spheroid body myopathy

AU - Foroud, Tatiana

AU - Pankratz, N.

AU - Batchman, A. P.

AU - Pauciulo, M. W.

AU - Vidal, Ruben

AU - Miravalle, L.

AU - Goebel, H. H.

AU - Cushman, L. J.

AU - Azzarelli, B.

AU - Horak, H.

AU - Farlow, Martin

AU - Nichols, W. C.

PY - 2005/12

Y1 - 2005/12

N2 - BACKGROUND: Spheroid body myopathy (SBM) is a rare, autosomal dominant, neuromuscular disorder, which has only been previously reported in a single large kindred. Identification of the mutated gene in this disorder may provide insight regarding abnormal neuromuscular function. METHODS: The authors completed a detailed clinical evaluation on an extensive kindred diagnosed with SBM. Genome-wide linkage analysis was performed to localize the disease gene to a specific chromosomal region. Further marker genotyping and screening of a positional, functional candidate gene were completed to detect the disease-causing mutation. Pathologic analysis of muscle biopsy was performed on three individuals. Biochemical studies were performed on one muscle biopsy specimen from an affected individual. RESULTS: Linkage to chromosome 5q23-5q31 was detected with a lod score of 2.9. Genotyping of additional markers in a larger sample of family members produced a maximum lod score of 6.1 and narrowed the critical interval to 12.2 cM. Screening of the candidate gene titin immunoglobulin domain protein (TTID, also known as MYOT) detected a cytosine-to-thymine mutation in exon 2 of all clinically affected family members. Similar pathologic changes were present in all muscle biopsy specimens. Immunohistologic and biochemical analysis revealed that the TTID protein, also known as myotilin, is a component of the insoluble protein aggregate. CONCLUSIONS: A novel mutation in the TTID gene results in the clinical and pathologic phenotype termed "spheroid body myopathy." Mutations in this gene also cause limb-girdle muscular dystrophy 1A and are associated with myofibrillar myopathy.

AB - BACKGROUND: Spheroid body myopathy (SBM) is a rare, autosomal dominant, neuromuscular disorder, which has only been previously reported in a single large kindred. Identification of the mutated gene in this disorder may provide insight regarding abnormal neuromuscular function. METHODS: The authors completed a detailed clinical evaluation on an extensive kindred diagnosed with SBM. Genome-wide linkage analysis was performed to localize the disease gene to a specific chromosomal region. Further marker genotyping and screening of a positional, functional candidate gene were completed to detect the disease-causing mutation. Pathologic analysis of muscle biopsy was performed on three individuals. Biochemical studies were performed on one muscle biopsy specimen from an affected individual. RESULTS: Linkage to chromosome 5q23-5q31 was detected with a lod score of 2.9. Genotyping of additional markers in a larger sample of family members produced a maximum lod score of 6.1 and narrowed the critical interval to 12.2 cM. Screening of the candidate gene titin immunoglobulin domain protein (TTID, also known as MYOT) detected a cytosine-to-thymine mutation in exon 2 of all clinically affected family members. Similar pathologic changes were present in all muscle biopsy specimens. Immunohistologic and biochemical analysis revealed that the TTID protein, also known as myotilin, is a component of the insoluble protein aggregate. CONCLUSIONS: A novel mutation in the TTID gene results in the clinical and pathologic phenotype termed "spheroid body myopathy." Mutations in this gene also cause limb-girdle muscular dystrophy 1A and are associated with myofibrillar myopathy.

UR - http://www.scopus.com/inward/record.url?scp=33645650403&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645650403&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000188872.28149.9a

DO - 10.1212/01.wnl.0000188872.28149.9a

M3 - Article

C2 - 16380616

AN - SCOPUS:33645650403

VL - 65

SP - 1936

EP - 1940

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 12

ER -